IL27 and autoimmune disease: More importantly, IL-27 has been evidenced to support antibody-driven autoimmune diseases through both direct and indirect effects on B cells [14, 15, 31], whereas another report revealed that IL-27 can directly inhibit the growth of leukemic B cells [16].